INNOVATE CORP. Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings
INNOVATE CORP. (VATE) reported Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings of $6.90 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings · last filed 2021-03-10
- INNOVATE CORP. other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for the quarter ending 2020-12-31 was $1.00M, a 58.33% decline year-over-year.
- INNOVATE CORP. other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for the quarter ending 2020-09-30 was $4.90M.
- INNOVATE CORP. other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for the quarter ending 2020-06-30 was $100.00K.
- INNOVATE CORP. other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for the quarter ending 2020-03-31 was $900.00K.
- INNOVATE CORP. other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for fiscal 2020 was $6.90M, a 187.50% increase from fiscal 2019.
- INNOVATE CORP. other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for fiscal 2019 was $2.40M.
| Period end | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings 3 month | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings 6 month | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings 9 month | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings 12 month |
|---|---|---|---|---|
| 2020-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $5.90M derived: sum of 2 quarters · filed 2021-03-10 | $6.00M derived: sum of 3 quarters · filed 2021-03-10 | $6.90M 10-K · filed 2021-03-10 |
| 2020-09-30 | $4.90M 10-Q · filed 2020-11-09 | $5.00M derived: sum of 2 quarters · filed 2020-11-09 | $5.90M 10-Q · filed 2020-11-09 | $8.30M derived: sum of 4 quarters · filed 2021-03-10 |
| 2020-06-30 | $100.00K 10-Q · filed 2020-08-10 | $1.00M 10-Q · filed 2020-08-10 | $3.40M derived: sum of 3 quarters · filed 2021-03-10 | $3.40M derived: sum of 4 quarters · filed 2021-03-10 |
| 2020-03-31 | $900.00K 10-Q · filed 2020-05-11 | $3.30M derived: sum of 2 quarters · filed 2021-03-10 | $3.30M derived: sum of 3 quarters · filed 2021-03-10 | $3.30M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $2.40M derived: sum of 2 quarters · filed 2021-03-10 | $2.40M derived: sum of 3 quarters · filed 2021-03-10 | $2.40M 10-K · filed 2021-03-10 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | $1.70M 8-K · filed 2020-10-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TECHPRECISION CORP (TPCS) | United States | $0.053B | 108.37 |
| Proto Labs Inc (PRLB) | United States | $2.226B | 64.02 |
| Arcosa, Inc. (ACA) | United States | $7.195B | 14.51 |
| VALMONT INDUSTRIES INC (VMI) | United States | $8.988B | 22.19 |